Michel Dard

Title: Michel Dard - Innovator in Integrin-Inhibitor Compounds

Introduction

Michel Dard is a notable inventor based in Seeheim-Jugenheim, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of peptide and peptide mimetic conjugates with integrin-inhibitor properties. With a total of three patents to his name, Dard's work has the potential to impact various medical treatments.

Latest Patents

Dard's latest patents include innovative compounds designed to serve as integrin inhibitors. The first patent describes compounds of the formula (1) B-Q-X, where B is a bioactive cell adhesive mediating molecule. This invention focuses on the treatment of illnesses such as osteoporosis, thrombosis, cardiac infarction, and arteriosclerosis. The compounds can also enhance the integration process of implants in tissue. The second patent further explores peptide and peptide mimetic derivatives with similar integrin-inhibitor properties, emphasizing their application in treating deficiencies and inflammations caused by implants.

Career Highlights

Michel Dard is currently associated with Biomet Deutschland GmbH, where he continues to innovate in the field of biocompatible materials. His work is crucial in advancing medical technologies that improve patient outcomes.

Collaborations

Dard collaborates with esteemed colleagues, including Joerg Meyer and Berthold Nies, who contribute to his research and development efforts.

Conclusion

Michel Dard's contributions to the field of integrin-inhibitor compounds highlight his role as a significant inventor in biochemistry. His innovative patents pave the way for advancements in medical treatments and implant technologies.